B CELL MALIGNANCIES

Clinical trials for B CELL MALIGNANCIES explained in plain language.

Never miss a new study

Get alerted when new B CELL MALIGNANCIES trials appear

Sign up with your email to follow new studies for B CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 5 Not yet finished but already full! 3 Completed 1

New drug combo shows promise for tough blood cancers

Disease control Completed

This early-phase study tested a new drug called INCB040093, alone or with another drug (itacitinib), in 121 adults with B-cell blood cancers that had come back or stopped responding to treatment. The main goal was to find safe doses and check for side effects. Researchers also lo…

Matched conditions: B CELL MALIGNANCIES

Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated May 14, 2026 12:05 UTC

B CELL MALIGNANCIES

Get alerted when new B CELL MALIGNANCIES trials appear

New drug combo shows promise for tough blood cancers